We do not produce drugs, we are just porters in the international pharmaceutical market💊

Lenvatinib, cabozantinib, olaparib, eltrombopag, palbociclib, venetoclax, gistrigen, trolagliptin, dasatinib, lapatinib, ibrutinib, osimertinib, crizotinib, erlotinib, brigatinib, tofacitinib, larotinib, doximetre, lenalidomide, tenofovir, abiraterone and other drugs💊 can provide direct mail service.

We do not produce drugs, we are just porters in the international pharmaceutical market💊

Alpelisib #PIK3CA#pivikto
150mg
[Indications] PIQRAY is a kinase inhibitor used in combination with fulvestrant FASLODEX for the treatment of postmenopausal women and men with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer.

We do not produce drugs, we are just porters in the international pharmaceutical market💊

tucatinib
everest
Indications: Combination of #trastuzumab and #capecitabine for the treatment of adult patients with advanced unresectable or metastatic #HER2-positive breast cancer, including #brain metastases in patients who have received one or more prior anti-#HER2-based regimens in the metastatic setting

We do not produce drugs, we are just porters in the international pharmaceutical market💊

Modafinil, armodafinil, the best-selling wakefulness-promoting drugs

We do not produce drugs, we are just porters in the international pharmaceutical market💊


Vyvanse 20/50mg

We do not produce drugs, we are just porters in the international pharmaceutical market💊

JM Methylphenidate

We do not produce drugs, we are just porters in the international pharmaceutical market💊

Novartis Ritalin

We do not produce drugs, we are just porters in the international pharmaceutical market💊

Misoprostol
The common trade name is Cytotec, which is a synthetic PGE1 drug.

We do not produce drugs, we are just porters in the international pharmaceutical market💊

modafinil
Narcolepsy is a central nervous system disease of unknown cause. Its main symptom is the inability to maintain sleep during the day. Staying awake or alert, causing uncontrollable sleep attacks and cataplexy. Patients often suffer from inability to control sleep. And unable to live a normal life. Modafinil, as a new type of wake-up drug, can help patients get rid of drowsiness during the day. It can maintain normal work without any adverse reactions such as abnormal excitement, so it is known as the "God who never sleeps". The best drug to date for treating this sleep disorder.

We do not produce drugs, we are just porters in the international pharmaceutical market💊

We do not produce drugs, we are just porters in the international pharmaceutical market💊

We do not produce drugs, we are just porters in the international pharmaceutical market💊

【Pulmonary fibrosis】 Indian Grammark-Nedadanib nindanib 150, a box of 30 pills Nintedanib is a selective immunosuppressive drug that inhibits the proliferation, migration and transformation of fibroblasts by blocking intracellular signaling and exerting anti-fibrotic and anti-inflammatory activities.

We do not produce drugs, we are just porters in the international pharmaceutical market💊

Koselugo
Selumetinib is an orally available, selective, non-competitive ATP-active MEK1/2 inhibitor developed by AstraZeneca. It was approved by the US FDA in 2020. Selumetinib can reduce tumor size in children and adolescents with neurofibromatosis type I (NF1) genetic syndrome and improve symptoms such as pain and reduced mobility caused by plexiform neurofibromas caused by NF1. Target: MEK1/MEK2

We do not produce drugs, we are just porters in the international pharmaceutical market💊

Cabozantinib, a drug known as tiger balm, has actually been used to treat liver cancer, lung cancer, thyroid cancer, kidney cancer and other cancers for a long time. The overall efficiency is also very high. And now there are products like the Bangladeshi version, which are much more cost-effective.

We do not produce drugs, we are just porters in the international pharmaceutical market💊

New packaging, black wine, 🙏 Holy drug for advanced lung cancer 🇧🇩 Bangladesh factory BEACONAZD9291💢 (osimertinib) 80mg Efficacy: It is a third-generation TKI targeted drug targeting the T790M gene mutation. It is mainly used to treat lung phosphocarcinoma/advanced non-small cell/advanced lung cancer 🇧🇩Bangladesh version of AZD9291 (osimertinib) A drug for non-small cell advanced lung cancer that can be developed using AZD-9291 , oral drugs for the treatment of patients with advanced non-small cell lung cancer. At the same time, the therapeutic effect is very obvious for patients with advanced lung cancer who take domestic Kemena, gefitinib (Iressa), and erlotinib hydrochloride (Tarceva) after drug resistance.

We do not produce drugs, we are just porters in the international pharmaceutical market💊

We do not produce drugs, we are just porters in the international pharmaceutical market💊

entrectinib
【Indications】 solid tumors This product is suitable for adults and children aged 12 years and above with solid tumors who meet the following conditions: - Well-validated test for diagnosis of neurotrophic tyrosine receptor kinase (NTRK) Fusion genes and do not include known acquired resistance mutations, - Patients with locally advanced, metastatic disease or in whom surgical resection may result in serious complications, to and - Patients for whom there is no satisfactory alternative treatment or for whom previous treatments have failed. This indication has been conditionally approved for marketing based on surrogate endpoints, and no clinical endpoint data have been obtained yet. The effectiveness and safety need to be further confirmed after marketing. Non-small cell lung cancer (NSCLC) This product is suitable for adults with ROS1-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). patient.

We do not produce drugs, we are just porters in the international pharmaceutical market💊

Gilteritinib Fumarate Tablets
【Indications】 This product is intended to treat patients carrying FMS-like tyrosine kinase 3 using a well-validated assay. Adult patients with relapsed or refractory acute myeloid leukemia (AML) who have (FLT3) mutations. FLT3 mutation Please refer to [Usage and Dosage] for testing requirements. 【Specification】 40 mg (calculated as C29H44N8O3).

We do not produce drugs, we are just porters in the international pharmaceutical market💊

Second-line drugs for kidney cancer: 【Product Name】Everolimus Tablets 5/10mg 【Indications】Indicated for the treatment of patients with advanced renal cell carcinoma who have failed previous treatment with sunitinib or sorafenib. [Dosage] Advanced RCC: (1) 10 gm once a day with or without food. (2) For patients with Child-hguP category B liver damage, reduce the AFINITOR dosage to 5 mg once a day.

We do not produce drugs, we are just porters in the international pharmaceutical market💊

We do not produce drugs, we are just porters in the international pharmaceutical market💊